LRRC75B/FAM211B Antikörper (Cy5.5)

Produktnummer ABIN1423657

Produktdetails anti-LRRC75B/FAM211B Antikörper (Cy5.5)

Target: LRRC75B/FAM211B (C22orf36) (Chromosome 22 Open Reading Frame 36 (C22orf36))

Reaktivität: Human, Ratte, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LRRC75B/FAM211B Antikörper ist konjugiert mit Cy5.5

Applikation: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C22orf36

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu LRRC75B/FAM211B

Target: LRRC75B/FAM211B (C22orf36) (Chromosome 22 Open Reading Frame 36 (C22orf36))

Andere Bezeichnung: C22orf36 (C22orf36 Produkte)

Synonyme: C22orf36 antikoerper, AI646023 antikoerper, leucine rich repeat containing 75B antikoerper, LRRC75B antikoerper, Lrrc75b antikoerper

Hintergrund:

Synonyms: C22orf36, Leucine-rich repeat-containing protein C22orf36, chromosome 22 open reading frame 36, LRC6X_HUMAN.

Background: C22orf36 is a 315 amino acid protein that contains two LRR (leucine-rich) repeats and exists as two alternatively spliced isoforms. C22orf36 is encoded by a gene located on human chromosome 22, which contains over 500 genes and about 49 million bases. As the second smallest human chromosome, chomosome 22 contains a wide variety of genes with numerous functions. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia.

Gen-ID: 388886